GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » Total Equity

FBLG (FibroBiologics) Total Equity : $2.74 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Total Equity?

FibroBiologics's total equity for the quarter that ended in Dec. 2024 was $2.74 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


FibroBiologics Total Equity Historical Data

The historical data trend for FibroBiologics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Total Equity Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Total Equity
-1.29 -4.00 1.25 2.74

FibroBiologics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 1.25 -3.86 -2.39 2.74 2.74

FibroBiologics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

FibroBiologics's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=16.445-13.71
=2.74

FibroBiologics's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=16.445-13.71
=2.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FibroBiologics Total Equity Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroBiologics Business Description

Traded in Other Exchanges
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.